Paratek Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $2.23M, a 42.7% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $10.3M, a 26.6% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.3M, a 14.1% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $14.3M, a 39.9% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $10.2M, a 28.3% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $10.3M $2.23M -$1.66M -42.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $12M $2.15M -$323K -13.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $12.3M $1.99M -$2.87M -59.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $15.2M $3.98M +$1.1M +38.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $14.1M $3.89M -$1.12M -22.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $15.2M $2.47M +$870K +54.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $14.3M $4.86M +$2.53M +109% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $11.8M $2.88M +$478K +19.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $11.3M $5M +$2.01M +67.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $9.31M $1.6M -$936K -36.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $10.2M $2.32M -$1.23M -34.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $11.5M $2.4M -$1.42M -37.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $12.9M $2.99M -$66K -2.16% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $13M $2.54M -$1.33M -34.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $14.3M $3.55M -$8.98M -71.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $23.3M $3.82M -$260K -6.37% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $23.5M $3.06M -$1.45M -32.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $25M $3.86M -$504K -11.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $25.5M $12.5M +$8.65M +223% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $16.8M $4.08M +$2K +0.05% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $16.8M $4.5M -$388K -7.93% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $17.2M $4.37M +$323K +7.99% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $16.9M $3.89M +$1.19M +44.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $15.7M $4.08M +$1.42M +53.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $14.3M $4.89M +$1.87M +61.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $12.4M $4.04M +$1.63M +67.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $10.8M $2.69M +$568K +26.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 $10.2M $2.66M +$1.15M +75.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $9.08M $3.02M +$1.84M +155% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $7.24M $2.42M +$2.18M +904% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $5.06M $2.12M +$1.92M +967% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $3.14M $1.51M +$1.03M +216% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $2.1M $1.19M +$1.17M +9015% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $932K $241K +$226K +1507% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $706K $199K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 $479K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $13K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $15K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2012 $707K +$242K +52% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $658K +$87K +15.2% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-13
Q3 2011 $465K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $571K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.